Why Still in Hospital After Hip Fracture Surgery?

NCT03265275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 182

Last updated 2020-11-30

No results posted yet for this study

Summary

At our institution, hip fracture patients are admitted and treated according to a fast track patient pathway. The aim of this study is to identify areas of this patient pathway that can be improved. To achieve this, the study will investigate the underlying reasons for the continued need for hospitalization on the consecutive days after hip fracture surgery.

Conditions

  • Hip Fractures

Interventions

OTHER

Fast track patient pathway

Prehospital services establish a working diagnosis of hip fracture and initiate first line treatment. In the emergency department a specially trained nurse triages the patient. Patients without signs of other acute disease or trauma and who have not previously been operated in the same hip are directly transported to the x-ray suite. The x-rays are reviewed by the radiographer and in case of an obvious fracture of the hip the patient is transported directly to the orthopedic ward where the patient is received by a nurse and seen by an orthopedic surgeon. The pathway includes standard procedures for blood sampling, pain relief, including a fascia iliaca compartment block, intravenous fluids, transfusion triggers, management of anticoagulants and premedication. The pathway puts focus on prevention of pressure sores, a short preoperative fasting period and early mobilization. Screening tools are used to assess for delirium, nutritional status and fall risk.

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER
  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Asbjorn Aaroen, Professor · University Hospital, Akershus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-11
Primary Completion
2020-02-28
Completion
2020-03-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03265275 on ClinicalTrials.gov